Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology - SALMAN, ANDAÇ (DERI ZUHREVI HASTALIKLAR DERNEGI, 2020)
Keywords: Atopic dermatitis; COVID-19; dupilumab; omalizumab; treatment; urticaria; OMALIZUMAB; METAANALYSIS